Cargando…
Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
BACKGROUND: Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) gene cause a familial form of amyotrophic lateral sclerosis (SOD1-ALS) with accumulation of misfolded SOD1 proteins as intracellular inclusions in spinal motor neurons. Oligomerization of SOD1 via abnormal disulfide crosslinks has b...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216565/ https://www.ncbi.nlm.nih.gov/pubmed/28057013 http://dx.doi.org/10.1186/s13024-016-0145-9 |
_version_ | 1782491937390985216 |
---|---|
author | Tokuda, Eiichi Anzai, Itsuki Nomura, Takao Toichi, Keisuke Watanabe, Masahiko Ohara, Shinji Watanabe, Seiji Yamanaka, Koji Morisaki, Yuta Misawa, Hidemi Furukawa, Yoshiaki |
author_facet | Tokuda, Eiichi Anzai, Itsuki Nomura, Takao Toichi, Keisuke Watanabe, Masahiko Ohara, Shinji Watanabe, Seiji Yamanaka, Koji Morisaki, Yuta Misawa, Hidemi Furukawa, Yoshiaki |
author_sort | Tokuda, Eiichi |
collection | PubMed |
description | BACKGROUND: Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) gene cause a familial form of amyotrophic lateral sclerosis (SOD1-ALS) with accumulation of misfolded SOD1 proteins as intracellular inclusions in spinal motor neurons. Oligomerization of SOD1 via abnormal disulfide crosslinks has been proposed as one of the misfolding pathways occurring in mutant SOD1; however, the pathological relevance of such oligomerization in the SOD1-ALS cases still remains obscure. METHODS: We prepared antibodies exclusively recognizing the SOD1 oligomers cross-linked via disulfide bonds in vitro. By using those antibodies, immunohistochemical examination and ELISA were mainly performed on the tissue samples of transgenic mice expressing mutant SOD1 proteins and also of human SOD1-ALS cases. RESULTS: We showed the recognition specificity of our antibodies exclusively toward the disulfide-crosslinked SOD1 oligomers by ELISA using various forms of purified SOD1 proteins in conformationally distinct states in vitro. Furthermore, the epitope of those antibodies was buried and inaccessible in the natively folded structure of SOD1. The antibodies were then found to specifically detect the pathological SOD1 species in the spinal motor neurons of the SOD1-ALS patients as well as the transgenic model mice. CONCLUSIONS: Our findings here suggest that the SOD1 oligomerization through the disulfide-crosslinking associates with exposure of the SOD1 structural interior and is a pathological process occurring in the SOD1-ALS cases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13024-016-0145-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5216565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52165652017-01-09 Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis Tokuda, Eiichi Anzai, Itsuki Nomura, Takao Toichi, Keisuke Watanabe, Masahiko Ohara, Shinji Watanabe, Seiji Yamanaka, Koji Morisaki, Yuta Misawa, Hidemi Furukawa, Yoshiaki Mol Neurodegener Research Article BACKGROUND: Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) gene cause a familial form of amyotrophic lateral sclerosis (SOD1-ALS) with accumulation of misfolded SOD1 proteins as intracellular inclusions in spinal motor neurons. Oligomerization of SOD1 via abnormal disulfide crosslinks has been proposed as one of the misfolding pathways occurring in mutant SOD1; however, the pathological relevance of such oligomerization in the SOD1-ALS cases still remains obscure. METHODS: We prepared antibodies exclusively recognizing the SOD1 oligomers cross-linked via disulfide bonds in vitro. By using those antibodies, immunohistochemical examination and ELISA were mainly performed on the tissue samples of transgenic mice expressing mutant SOD1 proteins and also of human SOD1-ALS cases. RESULTS: We showed the recognition specificity of our antibodies exclusively toward the disulfide-crosslinked SOD1 oligomers by ELISA using various forms of purified SOD1 proteins in conformationally distinct states in vitro. Furthermore, the epitope of those antibodies was buried and inaccessible in the natively folded structure of SOD1. The antibodies were then found to specifically detect the pathological SOD1 species in the spinal motor neurons of the SOD1-ALS patients as well as the transgenic model mice. CONCLUSIONS: Our findings here suggest that the SOD1 oligomerization through the disulfide-crosslinking associates with exposure of the SOD1 structural interior and is a pathological process occurring in the SOD1-ALS cases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13024-016-0145-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-05 /pmc/articles/PMC5216565/ /pubmed/28057013 http://dx.doi.org/10.1186/s13024-016-0145-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Tokuda, Eiichi Anzai, Itsuki Nomura, Takao Toichi, Keisuke Watanabe, Masahiko Ohara, Shinji Watanabe, Seiji Yamanaka, Koji Morisaki, Yuta Misawa, Hidemi Furukawa, Yoshiaki Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis |
title | Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis |
title_full | Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis |
title_fullStr | Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis |
title_full_unstemmed | Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis |
title_short | Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis |
title_sort | immunochemical characterization on pathological oligomers of mutant cu/zn-superoxide dismutase in amyotrophic lateral sclerosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216565/ https://www.ncbi.nlm.nih.gov/pubmed/28057013 http://dx.doi.org/10.1186/s13024-016-0145-9 |
work_keys_str_mv | AT tokudaeiichi immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis AT anzaiitsuki immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis AT nomuratakao immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis AT toichikeisuke immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis AT watanabemasahiko immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis AT oharashinji immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis AT watanabeseiji immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis AT yamanakakoji immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis AT morisakiyuta immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis AT misawahidemi immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis AT furukawayoshiaki immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis |